High-Throughput Capabilities Arrayjet's advanced inkjet platform offers high-speed, high-density microarray printing, making it well-suited for pharmaceutical and biotechnological companies seeking rapid, large-scale sample processing. This capability presents opportunities to target organizations aiming to increase throughput and reduce turnaround times.

Customizable Technology The company's versatile inkjet solutions can print any biological sample onto various substrates, appealing to research institutions and diagnostic labs looking for tailored, flexible lab automation tools. Emphasizing customization can help attract clients with specific assay development needs.

Strategic Partnerships Recent collaborations with Immunome and Chemspace illustrate Arrayjet’s focus on expanding its service offerings and market reach within antibody discovery and small molecule bioprinting sectors. These partnerships highlight sales opportunities across biotech and pharma industries emphasizing R&D and compound screening.

Innovation and Product Launches The launch of Mercury, a new ultra-low-volume liquid dispensing instrument, positions Arrayjet to target clients in precision liquid handling markets, including drug discovery and diagnostics. Leveraging new product entries can unlock upselling and expansion opportunities.

Global Expansion Potential With a significant focus on North American markets and the formation of Arrayjet Inc, the company presents sales prospects in North America’s growing biotech and pharmaceutical sectors. Offering localized support and demonstrating recent regional hires can bolster your outreach for market penetration.